Skip to main content
NEPH
NASDAQ Industrial Applications And Services

Nephros Q3 10-Q: Profit Holds, But Material Weakness Keeps Controls 'Not Effective'

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.09
Mkt Cap
$33.588M
52W Low
$2.663
52W High
$6.42
52W Position info
16% above low
Off High info
52% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NEPH sits 16% above its 52-week low of $2.663.

Summary

Nephros' Q3 10-Q confirms $5.6 million of revenue (up 18%) and $0.5 million of net income, but discloses that disclosure controls remain ineffective due to an unremediated ASC 606 revenue-recognition material weakness, with cash down to $4.5 million.


Key Events · Earnings and Guidance · NEPH

  • Q3 Revenue Up 18%, Profit $0.5M

    Net revenue rose to $5.6 million from $4.8 million a year earlier, and net income was $0.5 million versus $0.3 million; nine-month net income reached $1.8 million.

  • Material Weakness Still Unremediated

    Management concluded disclosure controls and procedures were not effective at September 30, 2026 due to a material weakness in internal control over financial reporting related to ASC 606 revenue allocation on multi-element contracts, first identified in the June 30, 2025 10-Q.

  • Gross Margin Compresses to 58%

    Quarterly gross margin fell to 58% from 61% on higher inventory shipping and handling costs including tariffs, plus a larger mix of lower-margin service revenue.

  • Cash Falls, Operations Burn $1.1M

    Cash and equivalents declined to $4.5 million from $5.4 million at December 31, 2025, with $1.1 million used in operating activities over nine months as inventory grew to $5.0 million from $3.2 million.


Analysis · NEPH · Industrial Applications And Services

The headline 8-K showed Nephros staying profitable in Q3 — $0.5 million of net income on $5.6 million of revenue, up 18% — but the full 10-Q carries a governance flag the earlier release did not: management concluded disclosure controls and procedures were not effective at September 30, 2026 because of a material weakness in internal control over financial reporting tied to ASC 606 revenue allocation on contracts combining product and service deliverables. That weakness was first identified in the June 30, 2025 10-Q and remains unremediated. Cash also tightened: balances fell to $4.5 million from $5.4 million at year-end, and operations consumed $1.1 million over nine months as inventory and receivables built, though management says current balances fund at least twelve months of operations. Gross margin compressed to 58% in the quarter from 61% on shipping, tariff and service-mix costs, and the nine-month result leans on roughly $0.6 million of IEEPA tariff refunds booked as a cost-of-goods reduction.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NEPH was trading at $3.09 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.6M. The 52-week trading range was $2.66 to $6.42. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NEPH - Latest Insights

NEPH
Nov 05, 2026, 4:10 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $2.61 info
Change: -$0.480 (-16%) info
Market Cap: $28.371M info
NEPH
Nov 05, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $2.61 info
Change: -$0.480 (-16%) info
Market Cap: $28.371M info
NEPH
Aug 10, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.38
Real-time Price: $2.61 info
Change: -$1.77 (-40%) info
Market Cap: $28.371M info
NEPH
Aug 06, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.22
Real-time Price: $2.61 info
Change: -$1.61 (-38%) info
Market Cap: $28.371M info
NEPH
May 07, 2026, 4:58 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.01
Real-time Price: $2.61 info
Change: -$0.400 (-13%) info
Market Cap: $28.371M info